2004
DOI: 10.1111/j.1440-1746.2003.03200.x
|View full text |Cite
|
Sign up to set email alerts
|

Severe Hepatotoxicity Associated With a N‐nitrosofenfluramine‐containing Weight‐loss Supplement: Report of Three Cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2004
2004
2016
2016

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(6 citation statements)
references
References 3 publications
1
5
0
Order By: Relevance
“…To test this hypothesis, the prevalence of CYP2C19 polymorphisms was examined in affected individuals; CYP2C19 is involved in N ‐nitrosofenfluramine metabolism. One of two Japanese patients tested carried the CYP2C19 poor metabolizer phenotype 14 . While this observation is consistent with the concept of a genetically determined reaction, it should be noted that up to 14% of the Japanese general population carry this metabolic variant.…”
Section: Resultssupporting
confidence: 79%
See 1 more Smart Citation
“…To test this hypothesis, the prevalence of CYP2C19 polymorphisms was examined in affected individuals; CYP2C19 is involved in N ‐nitrosofenfluramine metabolism. One of two Japanese patients tested carried the CYP2C19 poor metabolizer phenotype 14 . While this observation is consistent with the concept of a genetically determined reaction, it should be noted that up to 14% of the Japanese general population carry this metabolic variant.…”
Section: Resultssupporting
confidence: 79%
“…While this observation is consistent with the concept of a genetically determined reaction, it should be noted that up to 14% of the Japanese general population carry this metabolic variant. Further, acute hepatitis associated with Sennomotokounou has been documented in persons also carrying the CYP2C19 extensive metabolizer phenotype 14 . Therefore, a definitive relationship with a specific cytochrome polymorphism remains to be established.…”
Section: Resultsmentioning
confidence: 99%
“…Cytochrome P450 is most commonly responsible for hepatic metabolism of drugs, and genetic polymorphisms in cytochrome P450 genes have previously be shown to result in toxic accumulation of certain drugs or metabolites. For example, toxicity associated with weight-loss supplements containing N- nitrofenfluramine has been associated with cytochrome CYP2C19 phenotypes[23]. Mitochondrial injury, suggesting of toxic accumulation of N-nitrofenfluramine, was associated with a poor metabolizer phenotype; while, mitochondrial injury was absent in extensive metabolizers of the drug.…”
Section: Discussionmentioning
confidence: 99%
“…Excessive intake of N -nitroso-fenfluramine, which is generally used as a food supplement, has hepatotoxic effects [26,27]. Rapid depletion of ATP by impaired mitochondrial function and induction of DNA damage by the production of alkyl cations are thought to be the mechanism of N -nitroso-fenfluramine-induced cell death [28].…”
Section: Resultsmentioning
confidence: 99%